Advanced Biomed Inc Income (Loss) from Subsidiaries, before Tax
Advanced Biomed Inc (ADVB) reported Income (Loss) from Subsidiaries, before Tax of $2.07 million for the 6-month period ending 2024-12-31, per its 10-Q filed 2025-04-15.
Financial Statements › Income Statement › Other Income
us-gaap:IncomeLossFromSubsidiariesBeforeTax · last filed 2025-04-15
- 2024-12-31: Income (Loss) from Subsidiaries, before Tax 6 month $2.07M.
- 2023-12-31: Income (Loss) from Subsidiaries, before Tax 6 month $1.76M.
| Period end | Income (Loss) from Subsidiaries, before Tax 6 month |
|---|---|
| 2024-12-31 | $2.07M 10-Q · filed 2025-04-15 |
| 2023-12-31 | $1.76M 10-Q · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |